M
Martin J. Blaser
Researcher at Center for Advanced Biotechnology and Medicine
Publications - 841
Citations - 114575
Martin J. Blaser is an academic researcher from Center for Advanced Biotechnology and Medicine. The author has contributed to research in topics: Helicobacter pylori & CagA. The author has an hindex of 147, co-authored 820 publications receiving 104104 citations. Previous affiliations of Martin J. Blaser include Nagoya University & University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
Type B gastritis, aging, and Campylobacter pylori.
TL;DR: The incidence of gastritis, nearly all type B, increased with age, reaching 78% in those over 50 years old, and the relationship of these two entities has not been satisfactorily resolved.
Journal ArticleDOI
Quantifying bacterial evolution in the wild: A birthday problem for Campylobacter lineages.
Jessica K. Calland,Ben Pascoe,Sion C. Bayliss,Evangelos Mourkas,Elvire Berthenet,Elvire Berthenet,Harry A. Thorpe,Harry A. Thorpe,Matthew D. Hitchings,Edward J. Feil,Jukka Corander,Jukka Corander,Jukka Corander,Martin J. Blaser,Daniel Falush,Samuel K. Sheppard +15 more
TL;DR: In this paper, the authors estimate the molecular clock rate in Campylobacter that draws on the popular probability conundrum known as the "birthday problem" to estimate the rate of nucleotide change for the population.
Posted ContentDOI
Quantifying bacterial evolution in the wild: a birthday problem for Campylobacter lineages
Jessica K. Calland,Ben Pascoe,Sion C. Bayliss,Evangelos Mourkas,Elvire Berthenet,Harry A. Thorpe,Matthew D. Hitchings,Edward J. Feil,Martin J. Blaser,Daniel Falush,Samuel K. Sheppard +10 more
TL;DR: A new approach to estimate the molecular clock rate in Campylobacter is presented that draws on the popular probability conundrum known as the ‘birthday problem’ and provides a generalizable approach to calibrating mutation rates in populations of environmental bacteria.
Patent
Antisera against a PEB1 antigen from Campylobacter jejuni
TL;DR: An antigenic composition includes antigens obtainable from Campylobacter jejuni and may be used as a vaccine to induce protective antibodies against both CCL and CCL infection.